Ryerson (RYI) Financials

$21.24 +0.61 (+2.96%)

Closing price 05/6/2025 03:59 PM Eastern

Extended Trading

$21.14 -0.09 (-0.45%)

As of 04:35 AM Eastern

Annual Income Statements for Ryerson

This table shows Ryerson's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	391	146	-8.60
Consolidated Net Income / (Loss)	392	146	-7.30
Net Income / (Loss) Continuing Operations	392	146	-7.30
Total Pre-Tax Income	523	194	-7.40
Total Operating Income	579	228	32
Total Gross Profit	1,310	1,022	834
Total Revenue	6,324	5,109	4,599
Operating Revenue	6,324	5,109	4,599
Total Cost of Revenue	5,014	4,087	3,765
Operating Cost of Revenue	5,014	4,087	3,765
Total Operating Expenses	731	794	803
Selling, General & Admin Expense	735	794	801
Restructuring Charge	0.00	0.00	3.10
Other Special Charges / (Income)	-3.80	0.00	-1.60
Total Other Income / (Expense), net	-56	-34	-39
Interest Expense	55	35	43
Other Income / (Expense), net	-1.30	0.30	4.10
Income Tax Expense	131	47	-0.10
Net Income / (Loss) Attributable to Noncontrolling Interest	0.50	0.70	1.30
Basic Earnings per Share	$10.41	$4.17	($0.26)
Weighted Average Basic Shares Outstanding	36.99M	34.02M	31.85M
Diluted Earnings per Share	$10.21	$4.10	($0.26)
Weighted Average Diluted Shares Outstanding	36.99M	34.02M	31.85M
Weighted Average Basic & Diluted Shares Outstanding	36.99M	34.02M	31.85M
Cash Dividends to Common per Share	$0.54	$0.72	$0.75

This table shows Ryerson's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	55	-24	47	38	35	26	-7.60	9.90	-6.60	-4.30
Consolidated Net Income / (Loss)	55	-24	48	38	35	26	-7.40	10	-6.00	-4.20
Net Income / (Loss) Continuing Operations	55	-24	48	38	35	26	-7.40	10	-6.00	-4.20
Total Pre-Tax Income	76	-35	62	50	48	34	-9.50	13	-6.40	-4.80
Total Operating Income	85	-27	70	58	56	44	0.80	23	5.30	2.60
Total Gross Profit	271	163	264	261	249	247	218	224	202	191
Total Revenue	1,543	1,288	1,406	1,344	1,247	1,112	1,239	1,226	1,127	1,007
Operating Revenue	1,543	1,288	1,406	1,344	1,247	1,112	1,239	1,226	1,127	1,007
Total Cost of Revenue	1,272	1,125	1,142	1,083	997	865	1,022	1,002	925	816
Operating Cost of Revenue	1,272	1,125	1,142	1,083	997	865	1,022	1,002	925	816
Total Operating Expenses	187	191	194	203	193	204	217	201	197	189
Selling, General & Admin Expense	187	191	194	203	193	204	217	199	197	189
Total Other Income / (Expense), net	-8.90	-7.30	-7.70	-8.60	-8.10	-10	-10	-9.50	-12	-7.40
Interest Expense	9.10	27	7.60	8.30	9.30	9.50	10	11	12	10
Other Income / (Expense), net	0.20	20	-0.10	-0.30	1.20	-0.50	-0.20	1.80	-0.20	2.70
Income Tax Expense	21	-11	15	12	13	7.50	-2.10	3.00	-0.40	-0.60
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	0.30	0.20	0.00	0.30	0.20	0.20	0.40	0.60	0.10
Basic Earnings per Share	$1.49	($0.54)	$1.30	$1.07	$1.02	$0.78	($0.22)	$0.29	($0.20)	($0.13)
Weighted Average Basic Shares Outstanding	37.01M	36.99M	35.77M	34.39M	34.17M	34.02M	34.34M	33.20M	31.85M	31.85M
Diluted Earnings per Share	$1.46	($0.52)	$1.27	$1.06	$1.00	$0.77	($0.22)	$0.29	($0.20)	($0.13)
Weighted Average Diluted Shares Outstanding	37.01M	36.99M	35.77M	34.39M	34.17M	34.02M	34.34M	33.20M	31.85M	31.85M
Weighted Average Basic & Diluted Shares Outstanding	37.01M	36.99M	35.77M	34.39M	34.17M	34.02M	34.34M	33.20M	31.85M	31.85M
Cash Dividends to Common per Share	$0.15	$0.16	$0.17	$0.18	$0.18	$0.19	$0.19	$0.19	$0.19	$0.19

This table details how cash moves in and out of Ryerson's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-12	15	-26
Net Cash From Operating Activities	501	365	205
Net Cash From Continuing Operating Activities	501	365	205
Net Income / (Loss) Continuing Operations	392	146	-7.30
Consolidated Net Income / (Loss)	392	146	-7.30
Depreciation Expense	59	63	78
Non-Cash Adjustments To Reconcile Net Income	7.70	17	24
Changes in Operating Assets and Liabilities, net	43	139	111
Net Cash From Investing Activities	-160	-262	-143
Net Cash From Continuing Investing Activities	-160	-262	-143
Purchase of Property, Plant & Equipment	-105	-122	-100
Acquisitions	-57	-138	-44
Purchase of Investments	-2.00	0.00	0.00
Sale of Property, Plant & Equipment	8.00	0.50	2.10
Other Investing Activities, net	-3.90	-2.90	-1.10
Net Cash From Financing Activities	-350	-88	-87
Net Cash From Continuing Financing Activities	-350	-88	-87
Repayment of Debt	-333	-8.80	-8.60
Repurchase of Common Equity	-50	-114	-51
Payment of Dividends	-20	-25	-25
Issuance of Debt	26	70	32
Other Financing Activities, net	27	-11	-34
Effect of Exchange Rate Changes	-3.00	0.20	-1.50
Cash Interest Paid	38	30	41
Cash Income Taxes Paid	177	6.20	10

This table details how cash moves in and out of Ryerson's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	9.50	-12	4.50	-14	7.40	17	-12	-14	7.60	-7.50
Net Cash From Operating Activities	152	182	80	115	79	90	-48	26	135	92
Net Cash From Continuing Operating Activities	152	182	80	115	79	90	-48	26	135	92
Net Income / (Loss) Continuing Operations	55	-24	48	38	35	26	-7.40	10	-6.00	-4.20
Consolidated Net Income / (Loss)	55	-24	48	38	35	26	-7.40	10	-6.00	-4.20
Depreciation Expense	15	17	14	15	14	20	17	18	20	23
Non-Cash Adjustments To Reconcile Net Income	1.10	1.40	-2.30	4.00	2.00	13	6.30	2.50	4.00	11
Changes in Operating Assets and Liabilities, net	81	188	22	59	28	31	-64	-4.90	117	63
Net Cash From Investing Activities	-47	-69	-67	-58	-23	-115	-20	-23	-75	-24
Net Cash From Continuing Investing Activities	-47	-69	-67	-58	-23	-115	-20	-23	-75	-24
Purchase of Property, Plant & Equipment	-28	-34	-28	-46	-22	-25	-22	-23	-32	-24
Sale of Property, Plant & Equipment	0.80	-	0.00	0.10	-	0.40	1.40	0.10	0.40	0.20
Other Investing Activities, net	-	-3.90	-	-	-0.20	-2.70	-	-	-0.10	-0.60
Net Cash From Financing Activities	-89	-125	-9.90	-70	-49	41	56	-17	-52	-75
Net Cash From Continuing Financing Activities	-89	-125	-9.90	-70	-49	41	56	-17	-52	-75
Repayment of Debt	82	-139	-1.90	-2.40	-2.10	-2.40	-2.00	-3.80	-1.50	-1.30
Payment of Dividends	-5.50	-5.90	-6.00	-6.20	-6.30	-6.30	-6.40	-6.40	-6.00	-6.00
Issuance of Debt	-	-	28	1.00	-30	71	61	29	-3.60	-55
Other Financing Activities, net	-22	-5.40	23	-12	-6.80	-15	4.60	-22	-4.90	-12
Effect of Exchange Rate Changes	-5.40	0.70	0.70	-1.70	-	1.20	-0.40	-0.20	0.40	-1.30
Cash Interest Paid	6.30	7.30	6.10	6.80	7.80	9.20	11	9.60	12	8.40
Cash Income Taxes Paid	32	17	2.00	3.30	1.30	-0.40	6.40	1.10	1.00	1.80

This table presents Ryerson's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Total Assets	2,334	2,570	2,440
Total Current Assets	1,442	1,383	1,208
Cash & Equivalents	39	54	28
Restricted Cash	1.30	1.10	1.60
Accounts Receivable	514	468	426
Inventories, net	799	783	685
Prepaid Expenses	88	78	68
Plant, Property, & Equipment, net	458	590	637
Total Noncurrent Assets	434	597	595
Goodwill	129	158	162
Intangible Assets	51	74	68
Other Noncurrent Operating Assets	254	365	365
Total Liabilities & Shareholders' Equity	2,334	2,570	2,440
Total Liabilities	1,441	1,655	1,615
Total Current Liabilities	619	634	580
Short-Term Debt	5.80	8.20	0.70
Accounts Payable	438	463	441
Accrued Expenses	145	128	103
Current Employee Benefit Liabilities	4.80	4.00	3.70
Other Current Liabilities	25	31	32
Total Noncurrent Liabilities	822	1,021	1,035
Long-Term Debt	361	428	467
Noncurrent Deferred & Payable Income Tax Liabilities	114	136	129
Noncurrent Employee Benefit Liabilities	118	107	91
Other Noncurrent Operating Liabilities	229	351	348
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	893	915	825
Total Preferred & Common Equity	885	906	815
Preferred Stock	0.00	0.00	0.00
Total Common Equity	885	906	815
Common Stock	398	412	424
Retained Earnings	693	813	780
Treasury Stock	-61	-179	-234
Accumulated Other Comprehensive Income / (Loss)	-144	-140	-154
Noncontrolling Interest	7.90	8.60	9.20

This table presents Ryerson's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	2,547	2,402	2,522	2,434	2,720	2,591	2,533
Total Current Assets	1,701	1,457	1,448	1,359	1,525	1,389	1,301
Cash & Equivalents	51	44	30	37	42	28	35
Restricted Cash	1.20	1.30	1.10	1.10	1.10	1.20	1.80
Accounts Receivable	646	615	581	545	549	529	500
Inventories, net	933	711	754	699	841	744	681
Prepaid Expenses	70	85	83	76	93	87	84
Plant, Property, & Equipment, net	428	486	532	544	595	603	635
Plant, Property & Equipment, gross	854	938	994	1,011	1,081	1,099	1,135
Accumulated Depreciation	426	452	462	467	487	495	500
Total Noncurrent Assets	418	459	542	532	600	599	597
Goodwill	125	135	136	136	161	161	160
Intangible Assets	41	64	63	60	71	69	71
Other Noncurrent Operating Assets	252	259	343	335	368	369	366
Total Liabilities & Shareholders' Equity	2,547	2,402	2,522	2,434	2,720	2,591	2,533
Total Liabilities	1,655	1,521	1,655	1,543	1,823	1,705	1,691
Total Current Liabilities	705	665	712	634	729	583	585
Short-Term Debt	9.60	4.00	3.50	5.90	3.70	1.40	1.80
Accounts Payable	511	522	557	478	580	439	444
Accrued Expenses	92	71	73	72	111	69	104
Current Employee Benefit Liabilities	68	42	49	49	4.00	43	4.00
Other Current Liabilities	25	26	29	29	30	30	32
Total Noncurrent Liabilities	950	855	943	910	1,094	1,122	1,106
Long-Term Debt	467	391	393	360	494	524	520
Noncurrent Deferred & Payable Income Tax Liabilities	99	119	125	131	141	139	136
Noncurrent Employee Benefit Liabilities	153	112	112	111	106	103	97
Other Noncurrent Operating Liabilities	231	233	314	308	354	356	353
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	893	881	866	891	897	886	842
Total Preferred & Common Equity	885	873	858	883	889	878	833
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	885	873	858	883	889	878	833
Common Stock	396	401	404	408	416	420	423
Retained Earnings	723	734	765	794	799	803	790
Treasury Stock	-60	-118	-169	-173	-184	-198	-234
Accumulated Other Comprehensive Income / (Loss)	-173	-144	-142	-146	-142	-146	-146
Noncontrolling Interest	7.60	8.00	8.10	8.30	8.70	8.50	9.10

This table displays calculated financial ratios and metrics derived from Ryerson's official financial filings.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-
Revenue Growth	11.42%	-19.21%	-9.98%
EBITDA Growth	6.03%	-54.29%	-61.09%
EBIT Growth	6.08%	-60.44%	-84.41%
NOPAT Growth	4.68%	-60.21%	-87.21%
Net Income Growth	32.53%	-62.61%	-104.99%
EPS Growth	35.05%	-59.84%	-106.34%
Operating Cash Flow Growth	1,332.00%	-27.15%	-43.88%
Free Cash Flow Firm Growth	74.37%	-72.11%	-42.83%
Invested Capital Growth	7.78%	6.24%	-2.55%
Revenue Q/Q Growth	-3.74%	-3.33%	-2.23%
EBITDA Q/Q Growth	-28.94%	35.24%	-23.67%
EBIT Q/Q Growth	-31.07%	46.22%	-51.43%
NOPAT Q/Q Growth	-23.44%	42.48%	-58.90%
Net Income Q/Q Growth	-24.97%	51.55%	-131.88%
EPS Q/Q Growth	-24.09%	45.91%	-140.63%
Operating Cash Flow Q/Q Growth	17.54%	-20.04%	1.04%
Free Cash Flow Firm Q/Q Growth	11.95%	-56.21%	199.83%
Invested Capital Q/Q Growth	-7.43%	6.33%	-4.87%
Profitability Metrics	-	-	-
Gross Margin	20.72%	20.00%	18.14%
EBITDA Margin	10.06%	5.69%	2.46%
Operating Margin	9.15%	4.46%	0.69%
EBIT Margin	9.13%	4.47%	0.77%
Profit (Net Income) Margin	6.19%	2.87%	-0.16%
Tax Burden Percent	74.87%	75.58%	98.65%
Interest Burden Percent	90.56%	84.81%	-20.79%
Effective Tax Rate	25.13%	24.42%	0.00%
Return on Invested Capital (ROIC)	36.86%	13.71%	1.72%
ROIC Less NNEP Spread (ROIC-NNEP)	27.71%	6.36%	-5.44%
Return on Net Nonoperating Assets (RNNOA)	17.61%	2.49%	-2.56%
Return on Equity (ROE)	54.47%	16.20%	-0.84%
Cash Return on Invested Capital (CROIC)	29.37%	7.66%	4.30%
Operating Return on Assets (OROA)	24.57%	9.32%	1.42%
Return on Assets (ROA)	16.66%	5.97%	-0.29%
Return on Common Equity (ROCE)	53.89%	16.05%	-0.83%
Return on Equity Simple (ROE_SIMPLE)	44.23%	16.16%	-0.90%
Net Operating Profit after Tax (NOPAT)	433	172	22
NOPAT Margin	6.85%	3.37%	0.48%
Net Nonoperating Expense Percent (NNEP)	9.15%	7.35%	7.17%
Return On Investment Capital (ROIC_SIMPLE)	34.39%	12.76%	1.71%
Cost of Revenue to Revenue	79.28%	80.00%	81.86%
SG&A Expenses to Revenue	11.63%	15.53%	17.42%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	11.57%	15.53%	17.45%
Earnings before Interest and Taxes (EBIT)	577	228	36
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	636	291	113
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	1.20	1.27	0.72
Price to Tangible Book Value (P/TBV)	1.50	1.70	1.01
Price to Revenue (P/Rev)	0.17	0.22	0.13
Price to Earnings (P/E)	2.71	7.87	0.00
Dividend Yield	1.87%	2.14%	4.05%
Earnings Yield	36.86%	12.70%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.14	1.19	0.82
Enterprise Value to Revenue (EV/Rev)	0.22	0.30	0.23
Enterprise Value to EBITDA (EV/EBITDA)	2.19	5.28	9.16
Enterprise Value to EBIT (EV/EBIT)	2.42	6.73	29.12
Enterprise Value to NOPAT (EV/NOPAT)	3.22	8.92	47.02
Enterprise Value to Operating Cash Flow (EV/OCF)	2.78	4.21	5.06
Enterprise Value to Free Cash Flow (EV/FCFF)	4.04	15.96	18.83
Leverage & Solvency	-	-	-
Debt to Equity	0.41	0.48	0.57
Long-Term Debt to Equity	0.40	0.47	0.57
Financial Leverage	0.64	0.39	0.47
Leverage Ratio	3.27	2.71	2.88
Compound Leverage Factor	2.96	2.30	-0.60
Debt to Total Capital	29.13%	32.31%	36.18%
Short-Term Debt to Total Capital	0.46%	0.61%	0.05%
Long-Term Debt to Total Capital	28.67%	31.70%	36.13%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.63%	0.64%	0.71%
Common Equity to Total Capital	70.25%	67.05%	63.11%
Debt to EBITDA	0.58	1.50	4.13
Net Debt to EBITDA	0.51	1.31	3.87
Long-Term Debt to EBITDA	0.57	1.47	4.12
Debt to NOPAT	0.85	2.53	21.20
Net Debt to NOPAT	0.75	2.21	19.87
Long-Term Debt to NOPAT	0.83	2.48	21.17
Altman Z-Score	4.81	3.49	2.91
Noncontrolling Interest Sharing Ratio	1.06%	0.91%	1.02%
Liquidity Ratios	-	-	-
Current Ratio	2.33	2.18	2.08
Quick Ratio	0.89	0.82	0.78
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	345	96	55
Operating Cash Flow to CapEx	516.17%	300.74%	210.15%
Free Cash Flow to Firm to Interest Expense	6.34	2.78	1.28
Operating Cash Flow to Interest Expense	9.20	10.52	4.77
Operating Cash Flow Less CapEx to Interest Expense	7.41	7.02	2.50
Efficiency Ratios	-	-	-
Asset Turnover	2.69	2.08	1.84
Accounts Receivable Turnover	11.04	10.40	10.30
Inventory Turnover	6.15	5.17	5.13
Fixed Asset Turnover	14.94	9.75	7.50
Accounts Payable Turnover	10.90	9.06	8.33
Days Sales Outstanding (DSO)	33.05	35.08	35.45
Days Inventory Outstanding (DIO)	59.36	70.60	71.12
Days Payable Outstanding (DPO)	33.48	40.27	43.83
Cash Conversion Cycle (CCC)	58.93	65.41	62.74
Capital & Investment Metrics	-	-	-
Invested Capital	1,220	1,296	1,263
Invested Capital Turnover	5.38	4.06	3.60
Increase / (Decrease) in Invested Capital	88	76	-33
Enterprise Value (EV)	1,395	1,537	1,037
Market Capitalization	1,061	1,147	589
Book Value per Share	$23.91	$26.51	$25.60
Tangible Book Value per Share	$19.05	$19.74	$18.38
Total Capital	1,260	1,351	1,292
Total Debt	367	437	467
Total Long-Term Debt	361	428	467
Net Debt	327	381	438
Capital Expenditures (CapEx)	97	121	98
Debt-free, Cash-free Net Working Capital (DFCFNWC)	788	702	599
Debt-free Net Working Capital (DFNWC)	828	758	628
Net Working Capital (NWC)	822	750	628
Net Nonoperating Expense (NNE)	42	26	29
Net Nonoperating Obligations (NNO)	327	381	438
Total Depreciation and Amortization (D&A)	59	63	78
Debt-free, Cash-free Net Working Capital to Revenue	12.46%	13.75%	13.02%
Debt-free Net Working Capital to Revenue	13.10%	14.83%	13.66%
Net Working Capital to Revenue	13.01%	14.67%	13.65%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$10.41	$4.17	($0.26)
Adjusted Weighted Average Basic Shares Outstanding	36.99M	34.02M	31.85M
Adjusted Diluted Earnings per Share	$10.21	$4.10	($0.26)
Adjusted Weighted Average Diluted Shares Outstanding	36.99M	34.02M	31.85M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	36.99M	34.02M	31.85M
Normalized Net Operating Profit after Tax (NOPAT)	430	172	23
Normalized NOPAT Margin	6.81%	3.37%	0.50%
Pre Tax Income Margin	8.27%	3.79%	-0.16%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	10.59	6.58	0.83
NOPAT to Interest Expense	7.95	4.97	0.51
EBIT Less CapEx to Interest Expense	8.81	3.08	-1.44
NOPAT Less CapEx to Interest Expense	6.17	1.47	-1.75
Payout Ratios	-	-	-
Dividend Payout Ratio	5.08%	16.94%	-339.73%
Augmented Payout Ratio	17.85%	94.74%	-1,038.36%

This table displays calculated financial ratios and metrics derived from Ryerson's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-2.03%	-16.02%	-19.60%	-22.94%	-19.21%	-13.65%	-11.87%	-8.78%	-9.63%	-9.44%
EBITDA Growth	5.98%	-96.79%	-65.54%	-74.44%	-28.33%	633.72%	-78.47%	-41.72%	-65.40%	-55.63%
EBIT Growth	6.14%	-103.13%	-69.49%	-78.64%	-32.11%	644.30%	-99.14%	-57.59%	-91.13%	-87.67%
NOPAT Growth	-55.85%	-116.76%	-69.64%	-79.39%	-33.05%	276.02%	-98.95%	-59.97%	-91.00%	-94.61%
Net Income Growth	10.20%	-122.35%	-71.00%	-80.86%	-35.93%	209.24%	-115.58%	-72.61%	-117.00%	-116.15%
EPS Growth	14.96%	-119.12%	-69.54%	-79.22%	-31.51%	248.08%	-117.32%	-72.64%	-120.00%	-116.88%
Operating Cash Flow Growth	832.37%	70.04%	-2.55%	34.85%	-47.69%	-50.39%	-159.45%	-77.54%	69.74%	2.33%
Free Cash Flow Firm Growth	-100.70%	-5.65%	120.35%	156.62%	171.53%	60.50%	-460.20%	-186.66%	-174.99%	182.24%
Invested Capital Growth	24.29%	7.78%	1.66%	-8.20%	-7.51%	6.24%	9.78%	12.28%	8.93%	-2.55%
Revenue Q/Q Growth	-11.49%	-16.52%	9.15%	-4.45%	-7.21%	-10.77%	11.40%	-1.11%	-8.07%	-10.58%
EBITDA Q/Q Growth	-65.31%	-91.33%	758.27%	-12.56%	-2.74%	-11.25%	-71.47%	136.67%	-42.25%	13.82%
EBIT Q/Q Growth	-68.80%	-109.33%	339.38%	-17.02%	-0.86%	-25.22%	-98.60%	4,000.00%	-79.27%	3.92%
NOPAT Q/Q Growth	-71.22%	-131.14%	378.26%	-17.36%	-6.52%	-18.12%	-98.34%	3,053.06%	-78.99%	-50.94%
Net Income Q/Q Growth	-71.95%	-143.19%	299.58%	-20.84%	-6.12%	-26.35%	-128.46%	239.19%	-158.25%	30.00%
EPS Q/Q Growth	-71.37%	-135.62%	344.23%	-16.54%	-5.66%	-23.00%	-128.57%	231.82%	-168.97%	35.00%
Operating Cash Flow Q/Q Growth	77.31%	19.79%	-55.73%	43.41%	-31.22%	13.62%	-153.05%	154.18%	419.69%	-31.50%
Free Cash Flow Firm Q/Q Growth	28.02%	45.29%	131.04%	363.19%	-9.07%	-130.21%	-183.05%	-11.43%	21.31%	133.13%
Invested Capital Q/Q Growth	-1.79%	-7.43%	0.95%	0.02%	-1.05%	6.33%	4.31%	2.30%	-4.00%	-4.87%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	17.56%	12.66%	18.79%	19.42%	20.00%	22.22%	17.56%	18.24%	17.93%	18.97%
EBITDA Margin	6.43%	0.67%	5.95%	5.44%	5.70%	5.67%	1.45%	3.48%	2.18%	2.78%
Operating Margin	5.48%	-2.13%	4.98%	4.34%	4.52%	3.91%	0.06%	1.86%	0.47%	0.26%
EBIT Margin	5.49%	-0.61%	4.97%	4.32%	4.61%	3.87%	0.05%	2.01%	0.45%	0.53%
Profit (Net Income) Margin	3.57%	-1.85%	3.38%	2.80%	2.83%	2.34%	-0.60%	0.84%	-0.53%	-0.42%
Tax Burden Percent	72.88%	68.59%	76.24%	75.65%	73.24%	77.61%	77.89%	77.44%	93.75%	87.50%
Interest Burden Percent	89.26%	439.24%	89.13%	85.69%	83.83%	77.91%	-1,583.33%	54.07%	-125.49%	-90.57%
Effective Tax Rate	27.12%	0.00%	23.76%	24.35%	26.76%	22.39%	0.00%	22.56%	0.00%	0.00%
Return on Invested Capital (ROIC)	22.06%	-8.01%	18.59%	14.24%	13.78%	12.33%	0.17%	5.32%	1.22%	0.65%
ROIC Less NNEP Spread (ROIC-NNEP)	20.83%	-9.02%	17.22%	12.72%	12.21%	10.14%	-1.81%	3.61%	-1.17%	-0.82%
Return on Net Nonoperating Assets (RNNOA)	16.66%	-5.73%	9.29%	6.34%	5.15%	3.97%	-0.82%	1.77%	-0.55%	-0.39%
Return on Equity (ROE)	38.72%	-13.74%	27.88%	20.58%	18.93%	16.30%	-0.64%	7.09%	0.67%	0.26%
Cash Return on Invested Capital (CROIC)	25.95%	29.37%	23.81%	19.52%	17.34%	7.66%	-0.09%	-4.48%	-4.33%	4.30%
Operating Return on Assets (OROA)	14.46%	-1.65%	12.01%	9.26%	9.79%	8.05%	0.09%	3.79%	0.86%	0.97%
Return on Assets (ROA)	9.41%	-4.97%	8.16%	6.00%	6.01%	4.87%	-1.15%	1.59%	-1.01%	-0.77%
Return on Common Equity (ROCE)	38.28%	-13.60%	27.60%	20.40%	18.76%	16.15%	-0.64%	7.02%	0.66%	0.26%
Return on Equity Simple (ROE_SIMPLE)	58.96%	0.00%	31.52%	13.56%	10.94%	0.00%	10.30%	7.31%	2.75%	0.00%
Net Operating Profit after Tax (NOPAT)	62	-19	53	44	41	34	0.56	18	3.71	1.82
NOPAT Margin	3.99%	-1.49%	3.80%	3.28%	3.31%	3.04%	0.05%	1.44%	0.33%	0.18%
Net Nonoperating Expense Percent (NNEP)	1.23%	1.01%	1.37%	1.52%	1.58%	2.19%	1.98%	1.71%	2.39%	1.47%
Return On Investment Capital (ROIC_SIMPLE)	-	-1.52%	-	-	-	2.50%	-	-	-	0.14%
Cost of Revenue to Revenue	82.44%	87.34%	81.21%	80.58%	80.00%	77.78%	82.44%	81.76%	82.07%	81.03%
SG&A Expenses to Revenue	12.09%	14.79%	13.81%	15.08%	15.48%	18.31%	17.50%	16.24%	17.48%	18.71%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	12.09%	14.79%	13.81%	15.08%	15.48%	18.31%	17.50%	16.38%	17.46%	18.71%
Earnings before Interest and Taxes (EBIT)	85	-7.90	70	58	58	43	0.60	25	5.10	5.30
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	99	8.60	84	73	71	63	18	43	25	28
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.03	1.20	1.49	1.76	1.10	1.27	1.28	0.76	0.79	0.72
Price to Tangible Book Value (P/TBV)	1.27	1.50	1.93	2.29	1.41	1.70	1.73	1.03	1.10	1.01
Price to Revenue (P/Rev)	0.14	0.17	0.22	0.27	0.18	0.22	0.23	0.14	0.14	0.13
Price to Earnings (P/E)	1.75	2.71	4.74	13.03	10.12	7.87	12.50	10.61	30.75	0.00
Dividend Yield	1.86%	1.87%	1.72%	1.56%	2.46%	2.14%	2.21%	3.81%	3.75%	4.05%
Earnings Yield	57.01%	36.86%	21.08%	7.67%	9.88%	12.70%	8.00%	9.42%	3.25%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.02	1.14	1.35	1.53	1.07	1.19	1.18	0.85	0.87	0.82
Enterprise Value to Revenue (EV/Rev)	0.21	0.22	0.28	0.34	0.25	0.30	0.32	0.24	0.25	0.23
Enterprise Value to EBITDA (EV/EBITDA)	1.50	2.19	3.64	7.75	6.07	5.28	7.09	6.03	7.79	9.16
Enterprise Value to EBIT (EV/EBIT)	1.61	2.42	4.19	10.27	8.36	6.73	10.04	9.34	15.76	29.12
Enterprise Value to NOPAT (EV/NOPAT)	2.38	3.22	5.34	13.35	10.79	8.92	13.40	12.67	21.53	47.02
Enterprise Value to Operating Cash Flow (EV/OCF)	3.16	2.78	3.33	3.56	2.86	4.21	6.75	7.96	5.70	5.06
Enterprise Value to Free Cash Flow (EV/FCFF)	4.37	4.04	5.71	7.50	5.94	15.96	0.00	0.00	0.00	18.83
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.53	0.41	0.45	0.46	0.41	0.48	0.55	0.59	0.62	0.57
Long-Term Debt to Equity	0.52	0.40	0.44	0.45	0.40	0.47	0.55	0.59	0.62	0.57
Financial Leverage	0.80	0.64	0.54	0.50	0.42	0.39	0.45	0.49	0.47	0.47
Leverage Ratio	3.78	3.27	3.12	3.03	2.79	2.71	2.88	2.92	2.87	2.88
Compound Leverage Factor	3.37	14.36	2.78	2.60	2.34	2.11	-45.60	1.58	-3.60	-2.61
Debt to Total Capital	34.82%	29.13%	30.96%	31.37%	29.11%	32.31%	35.66%	37.21%	38.27%	36.18%
Short-Term Debt to Total Capital	0.70%	0.46%	0.31%	0.28%	0.47%	0.61%	0.27%	0.10%	0.13%	0.05%
Long-Term Debt to Total Capital	34.12%	28.67%	30.65%	31.10%	28.64%	31.70%	35.40%	37.12%	38.14%	36.13%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.55%	0.63%	0.63%	0.64%	0.66%	0.64%	0.62%	0.60%	0.67%	0.71%
Common Equity to Total Capital	64.62%	70.25%	68.41%	67.98%	70.23%	67.05%	63.71%	62.18%	61.06%	63.11%
Debt to EBITDA	0.53	0.58	0.87	1.63	1.70	1.50	2.21	2.70	3.52	4.13
Net Debt to EBITDA	0.47	0.51	0.77	1.50	1.52	1.31	2.02	2.55	3.27	3.87
Long-Term Debt to EBITDA	0.52	0.57	0.86	1.61	1.67	1.47	2.19	2.69	3.51	4.12
Debt to NOPAT	0.84	0.85	1.27	2.81	3.02	2.53	4.17	5.67	9.73	21.20
Net Debt to NOPAT	0.75	0.75	1.13	2.59	2.71	2.21	3.81	5.36	9.04	19.87
Long-Term Debt to NOPAT	0.83	0.83	1.26	2.78	2.98	2.48	4.14	5.66	9.70	21.17
Altman Z-Score	3.89	3.98	3.92	3.61	3.44	3.25	2.95	2.94	2.87	2.87
Noncontrolling Interest Sharing Ratio	1.12%	1.06%	0.98%	0.91%	0.89%	0.91%	0.94%	0.95%	1.00%	1.02%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.41	2.33	2.19	2.03	2.14	2.18	2.09	2.38	2.22	2.08
Quick Ratio	0.99	0.89	0.99	0.86	0.92	0.82	0.81	0.96	0.91	0.78
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-196	-107	33	154	140	-42	-120	-134	-105	35
Operating Cash Flow to CapEx	549.28%	535.69%	289.21%	249.57%	354.02%	360.40%	-234.31%	114.60%	431.41%	395.71%
Free Cash Flow to Firm to Interest Expense	-21.53	-4.00	4.38	18.57	15.07	-4.46	-11.87	-11.82	-9.14	3.45
Operating Cash Flow to Interest Expense	16.66	6.78	10.58	13.89	8.53	9.48	-4.73	2.29	11.70	9.13
Operating Cash Flow Less CapEx to Interest Expense	13.63	5.51	6.92	8.33	6.12	6.85	-6.75	0.29	8.99	6.82
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	2.63	2.69	2.42	2.14	2.12	2.08	1.93	1.89	1.89	1.84
Accounts Receivable Turnover	9.76	11.04	8.52	8.35	8.88	10.40	8.49	8.69	9.00	10.30
Inventory Turnover	5.70	6.15	6.22	5.23	5.33	5.17	5.11	5.19	5.53	5.13
Fixed Asset Turnover	16.55	14.94	13.51	11.88	10.87	9.75	9.14	8.50	7.98	7.50
Accounts Payable Turnover	9.07	10.90	8.57	7.62	8.79	9.06	7.20	7.80	8.27	8.33
Days Sales Outstanding (DSO)	37.38	33.05	42.84	43.72	41.12	35.08	42.98	41.98	40.53	35.45
Days Inventory Outstanding (DIO)	64.08	59.36	58.72	69.73	68.52	70.60	71.40	70.33	66.06	71.12
Days Payable Outstanding (DPO)	40.25	33.48	42.61	47.93	41.55	40.27	50.70	46.81	44.13	43.83
Cash Conversion Cycle (CCC)	61.20	58.93	58.95	65.53	68.10	65.41	63.68	65.50	62.47	62.74
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,317	1,220	1,231	1,231	1,219	1,296	1,352	1,383	1,327	1,263
Invested Capital Turnover	5.53	5.38	4.90	4.34	4.17	4.06	3.83	3.69	3.70	3.60
Increase / (Decrease) in Invested Capital	258	88	20	-110	-99	76	120	151	109	-33
Enterprise Value (EV)	1,347	1,395	1,661	1,884	1,305	1,537	1,598	1,174	1,155	1,037
Market Capitalization	915	1,061	1,303	1,510	970	1,147	1,135	670	661	589
Book Value per Share	$23.88	$23.91	$23.60	$24.00	$25.67	$26.51	$25.88	$25.57	$25.09	$25.60
Tangible Book Value per Share	$19.40	$19.05	$18.21	$18.45	$19.95	$19.74	$19.12	$18.88	$18.12	$18.38
Total Capital	1,370	1,260	1,276	1,263	1,257	1,351	1,395	1,412	1,364	1,292
Total Debt	477	367	395	396	366	437	497	525	522	467
Total Long-Term Debt	467	361	391	393	360	428	494	524	520	467
Net Debt	425	327	350	365	327	381	454	496	485	438
Capital Expenditures (CapEx)	28	34	28	46	22	25	20	23	31	23
Debt-free, Cash-free Net Working Capital (DFCFNWC)	954	788	750	708	692	702	757	778	681	599
Debt-free Net Working Capital (DFNWC)	1,006	828	795	739	731	758	800	808	718	628
Net Working Capital (NWC)	996	822	791	735	725	750	796	806	716	628
Net Nonoperating Expense (NNE)	6.49	4.62	5.87	6.51	5.93	7.76	7.96	7.36	9.71	6.02
Net Nonoperating Obligations (NNO)	425	327	350	365	327	381	454	496	485	438
Total Depreciation and Amortization (D&A)	15	17	14	15	14	20	17	18	20	23
Debt-free, Cash-free Net Working Capital to Revenue	14.51%	12.46%	12.54%	12.68%	13.10%	13.75%	15.32%	16.13%	14.48%	13.02%
Debt-free Net Working Capital to Revenue	15.31%	13.10%	13.29%	13.24%	13.83%	14.83%	16.19%	16.74%	15.27%	13.66%
Net Working Capital to Revenue	15.16%	13.01%	13.23%	13.18%	13.72%	14.67%	16.11%	16.71%	15.23%	13.65%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.49	($0.54)	$1.30	$1.07	$1.02	$0.78	($0.22)	$0.29	($0.20)	($0.13)
Adjusted Weighted Average Basic Shares Outstanding	37.01M	36.99M	35.77M	34.39M	34.17M	34.02M	34.34M	33.20M	31.85M	31.85M
Adjusted Diluted Earnings per Share	$1.46	($0.52)	$1.27	$1.06	$1.00	$0.77	($0.22)	$0.29	($0.20)	($0.13)
Adjusted Weighted Average Diluted Shares Outstanding	37.01M	36.99M	35.77M	34.39M	34.17M	34.02M	34.34M	33.20M	31.85M	31.85M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	37.01M	36.99M	35.77M	34.39M	34.17M	34.02M	34.34M	33.20M	31.85M	31.85M
Normalized Net Operating Profit after Tax (NOPAT)	62	-19	53	44	41	34	0.56	19	3.57	1.82
Normalized NOPAT Margin	3.99%	-1.49%	3.80%	3.28%	3.31%	3.04%	0.05%	1.55%	0.32%	0.18%
Pre Tax Income Margin	4.90%	-2.69%	4.43%	3.70%	3.87%	3.01%	-0.77%	1.09%	-0.57%	-0.48%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	9.31	-0.29	9.20	6.99	6.18	4.53	0.06	2.18	0.44	0.52
NOPAT to Interest Expense	6.77	-0.72	7.02	5.31	4.43	3.55	0.06	1.56	0.32	0.18
EBIT Less CapEx to Interest Expense	6.27	-1.56	5.54	1.42	3.77	1.89	-1.96	0.18	-2.27	-1.78
NOPAT Less CapEx to Interest Expense	3.73	-1.98	3.36	-0.25	2.03	0.92	-1.96	-0.44	-2.39	-2.13
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	3.32%	5.08%	8.03%	20.27%	25.26%	16.94%	27.54%	39.56%	109.61%	-339.73%
Augmented Payout Ratio	12.90%	17.85%	45.35%	110.82%	137.58%	94.74%	94.97%	78.97%	359.83%	-1,038.36%

Frequently Asked Questions About Ryerson's Financials

When does Ryerson's fiscal year end?

According to the most recent income statement we have on file, Ryerson's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Ryerson's net income changed over the last 2 years?

Ryerson's net income appears to be on a downward trend, with a most recent value of -$7.30 million in 2024, falling from $391.50 million in 2022. The previous period was $146.40 million in 2023. See Ryerson's forecast for analyst expectations on what’s next for the company.

What is Ryerson's operating income?

Ryerson's total operating income in 2024 was $31.50 million, based on the following breakdown:

Total Gross Profit: $834.20 million
Total Operating Expenses: $802.70 million

How has Ryerson revenue changed over the last 2 years?

Over the last 2 years, Ryerson's total revenue changed from $6.32 billion in 2022 to $4.60 billion in 2024, a change of -27.3%.

How much debt does Ryerson have?

Ryerson's total liabilities were at $1.62 billion at the end of 2024, a 2.4% decrease from 2023, and a 12.1% increase since 2022.

How much cash does Ryerson have?

In the past 2 years, Ryerson's cash and equivalents has ranged from $27.70 million in 2024 to $54.30 million in 2023, and is currently $27.70 million as of their latest financial filing in 2024.

How has Ryerson's book value per share changed over the last 2 years?

Over the last 2 years, Ryerson's book value per share changed from 23.91 in 2022 to 25.60 in 2024, a change of 7.1%.

Related Companies

This page (NYSE:RYI) was last updated on 5/7/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ryerson (RYI) Financials

Frequently Asked Questions About Ryerson's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ryerson (RYI) Financials

Annual Income Statements for Ryerson

Quarterly Income Statements for Ryerson

Annual Cash Flow Statements for Ryerson

Quarterly Cash Flow Statements for Ryerson

Annual Balance Sheets for Ryerson

Quarterly Balance Sheets for Ryerson

Annual Metrics and Ratios for Ryerson

Quarterly Metrics and Ratios for Ryerson

Frequently Asked Questions About Ryerson's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools